Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report) EVP Mark Brosius sold 46 shares of the business’s stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $361.23, for a total value of $16,616.58. Following the completion of the sale, the executive vice president directly owned 835 shares of the company’s stock, valued at approximately $301,627.05. This trade represents a 5.22% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Mark Brosius also recently made the following trade(s):
- On Friday, September 11th, Mark Brosius sold 25 shares of Intuitive Surgical stock. The shares were sold at an average price of $365.79, for a total value of $9,144.75.
- On Wednesday, September 9th, Mark Brosius sold 23 shares of Intuitive Surgical stock. The stock was sold at an average price of $350.20, for a total value of $8,054.60.
- On Friday, August 21st, Mark Brosius sold 77 shares of Intuitive Surgical stock. The shares were sold at an average price of $375.57, for a total value of $28,918.89.
- On Wednesday, August 19th, Mark Brosius sold 77 shares of Intuitive Surgical stock. The shares were sold at an average price of $394.26, for a total value of $30,358.02.
- On Monday, August 17th, Mark Brosius sold 77 shares of Intuitive Surgical stock. The stock was sold at an average price of $390.67, for a total transaction of $30,081.59.
- On Friday, July 31st, Mark Brosius sold 28 shares of Intuitive Surgical stock. The stock was sold at an average price of $351.00, for a total transaction of $9,828.00.
- On Wednesday, July 29th, Mark Brosius sold 28 shares of Intuitive Surgical stock. The shares were sold at an average price of $360.21, for a total transaction of $10,085.88.
- On Monday, July 27th, Mark Brosius sold 28 shares of Intuitive Surgical stock. The shares were sold at an average price of $344.00, for a total transaction of $9,632.00.
- On Friday, June 12th, Mark Brosius sold 25 shares of Intuitive Surgical stock. The stock was sold at an average price of $414.13, for a total transaction of $10,353.25.
Intuitive Surgical Trading Up 2.4%
ISRG stock opened at $369.15 on Friday. The firm’s 50-day moving average price is $376.27 and its two-hundred day moving average price is $423.82. Intuitive Surgical, Inc. has a 12-month low of $328.57 and a 12-month high of $603.88. The stock has a market capitalization of $130.41 billion, a price-to-earnings ratio of 42.29, a PEG ratio of 2.72 and a beta of 1.47.
Institutional Investors Weigh In On Intuitive Surgical
Several hedge funds and other institutional investors have recently added to or reduced their stakes in ISRG. California State Teachers Retirement System grew its position in shares of Intuitive Surgical by 39,531.1% in the 2nd quarter. California State Teachers Retirement System now owns 213,725,958 shares of the medical equipment provider’s stock worth $84,994,539,000 after buying an additional 213,186,670 shares during the period. State Street Corp lifted its position in Intuitive Surgical by 1.0% during the 4th quarter. State Street Corp now owns 15,701,591 shares of the medical equipment provider’s stock valued at $8,892,753,000 after acquiring an additional 162,264 shares during the period. Capital World Investors boosted its stake in Intuitive Surgical by 1.7% during the fourth quarter. Capital World Investors now owns 7,856,018 shares of the medical equipment provider’s stock worth $4,449,491,000 after acquiring an additional 127,526 shares in the last quarter. Norges Bank bought a new stake in Intuitive Surgical during the fourth quarter worth about $2,856,987,000. Finally, Invesco Ltd. grew its holdings in Intuitive Surgical by 17.4% in the fourth quarter. Invesco Ltd. now owns 4,128,735 shares of the medical equipment provider’s stock worth $2,338,350,000 after purchasing an additional 611,268 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of brokerages recently commented on ISRG. Deutsche Bank Aktiengesellschaft decreased their target price on Intuitive Surgical from $440.00 to $366.00 and set a “sell” rating for the company in a report on Tuesday, June 2nd. Stifel Nicolaus reduced their price objective on shares of Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating on the stock in a research report on Friday, July 17th. Oppenheimer upgraded shares of Intuitive Surgical from a “market perform” rating to an “outperform” rating and set a $500.00 price objective for the company in a report on Wednesday, August 12th. Sanford C. Bernstein reaffirmed an “outperform” rating on shares of Intuitive Surgical in a research report on Wednesday, August 12th. Finally, Citigroup cut their target price on shares of Intuitive Surgical from $590.00 to $500.00 and set a “buy” rating on the stock in a research note on Friday, July 17th. Twenty-two equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $508.68.
View Our Latest Research Report on Intuitive Surgical
About Intuitive Surgical
Intuitive Surgical, Inc is a medical technology company that develops and manufactures robotic-assisted surgical systems and related products. Its technology is designed to support surgeons during minimally invasive procedures by providing enhanced visualization, instrument control and dexterity.
The company’s principal product is the da Vinci Surgical System, which is used across a range of specialties, including general surgery, urology, gynecology, cardiothoracic surgery and other procedures.
Featured Articles
- Five stocks we like better than Intuitive Surgical
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
